Healthcare & Life Sciences
MoglingBio
MoglingBio is a startup, most recent round Seed, 1 tracked investor.
seed
seed
Stage
1
Investors
About MoglingBio
MoglingBio is a startup. Its most recent tracked round is Seed. Brouky records 1 investor associated with the company.
MoglingBio is developing pharmacological approaches to rejuvenate aged hematopoietic (blood-forming) stem cells by normalizing activity of the CDC42 protein, with the aim of restoring stem cell structure and function to improve blood and immune cell production and treat age-related blood and immune dysfunction.
Explore MoglingBio's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.